Now I have sufficient calibration data. Let me compile my final assessment.

**Calibration anchors retrieved across all rounds:**

| Anchor | Path | Avg Score | Round | Comparison |
|--------|------|-----------|-------|------------|
| KL Divergence GFlowNets | Uj0h13lVrR | 1.00 | R1 | Irrelevant topic, poor quality — not comparable |
| Budget-constrained Survival | y2ch7iQSJu | 2.00 | R1 | Survival data but confused methodology, no CP — much weaker paper |
| Regression CP under Bias | v8RDgaEtE2 | 2.50 | R1 | CP topic but rejected for weak contribution — weaker paper |
| Conformal Prediction Truncating | uUkpYafkVl | 4.75 | R1 | CP method but simpler setting — weaker paper |
| Survival Analysis via Density Est. | XgYPzNtz0s | 4.60 | R1 | Survival analysis but no causal/CP — different focus |
| **Conformal Prediction for Dose-Response** | **AKAz88zYLB** | **5.80** | **R2** | **Most topically similar: CP + causal + weighted conformal. Rejected — no theory, limited novelty. Paper under review is stronger.** |
| **Probabilistic CP with Cond. Validity** | **Nfd7z9d6Bb** | **6.00** | **R2** | **CP theory paper, accepted with all 6s. Similar depth but cleaner presentation.** |
| **Constructing CIs for ATE** | **BHFs80Jf5V** | **6.50** | **R2** | **Causal inference + CIs, accepted. Novel contribution, solid theory.** |
| **Wasserstein-Reg. CP** | **aJ3tiX1Tu4** | **6.67** | **R2** | **CP under distribution shift, accepted. Stronger theory, cleaner presentation.** |
| **Conformal Risk Control** | **33XGfHLtZg** | **7.00** | **R1** | **Foundational CP extension, accepted. Broader impact, cleaner theory.** |
| CATE Models Benchmark | Q2bJ2qgcP1 | 6.00 | R2 | CATE estimation benchmark — different focus |
| CP for Deep Classifier | Dtxc7mlKRg | 4.60 | R1 | CP for classification — less relevant |

**Initial bracket:** Based on these anchors, the paper sits clearly above the rejected Dose-Response CP paper (5.80) which lacks theory and handles a simpler setting, and below the accepted Conformal Risk Control (7.00) and Wasserstein-CP (6.67) papers which have cleaner theory. It's comparable to the Probabilistic CP paper (6.00, accepted) in contribution depth. **Bracket: 5.5–6.5.**

The paper under review handles a harder setting (general right-censored survival + counterfactuals) than the Dose-Response CP paper, has genuine theoretical contributions (doubly robust, finite-sample bounds), and real clinical validation. But it has a messy central derivation and overstates its coverage claims. This places it at the level of the Probabilistic CP paper (6.0) — genuine contribution with some presentation/theory issues.

## Summary
This paper proposes a conformalized survival counterfactual prediction method that provides lower prediction bounds (LPBs) for counterfactual survival times under different treatments in general right-censored data. The core technical contribution is a reweighting scheme that transforms the coverage probability into a weighted conformal inference problem, yielding a finite-sample bound whose error depends on weight estimation quality, along with a doubly robust asymptotic guarantee. The method is validated on synthetic data and a lung cancer clinical dataset.

## Strengths
- **Novel setting combining general right-censored data with exact marginal coverage**: Prior work (Candès et al. 2023, Gui et al. 2024) only handles Type-I censoring, while Davidov et al. (2025) handles general right-censored data but only with PAC guarantees. This paper is the first to combine both, as supported by Theorems 4.1 and 4.2.

- **Doubly robust property (Theorem 4.2)**: Valid asymptotic coverage holds when *either* the weight function γ(x) or the conditional quantile estimator is consistently estimated. This is meaningful for survival analysis where either model component could be misspecified.

- **Strong empirical evidence of robustness**: Figure 3 demonstrates that PAC-based methods (Focus, Fused) lose coverage under outlier contamination while the proposed method maintains near-nominal 90% coverage, providing direct evidence of the practical value of the exact guarantee over PAC guarantees.

- **Clinically meaningful real-data validation**: The application to 541 lung cancer patients (Figure 4) shows LPB patterns consistent with established clinical literature (VMAT outperforms IMRT per Hunt et al. 2022), and Figure 5 shows LPBs correlate appropriately with known prognostic factors.

- **Clean algorithmic presentation**: Algorithm 1 is self-contained, covering data splitting, score computation, weight estimation, and conformal calibration.

## Weaknesses

### Fatal
None

### Major
- **Erroneous intermediate steps in Equation (1) derivation** — The paper's central derivation contains presentation errors that are problematic for a theory paper. At step (ii), the factor 1/p(e=1|X,W=w) is introduced with an equality sign (line 132), but since p(e=1|x,W=w) ≤ 1, multiplying by its reciprocal ≥ 1 cannot preserve equality. The paper says "(ii) comes from the tower property" (line 140) but the tower property does not justify multiplying by a factor ≥ 1 with equality. Step (iii) then applies an inequality. The final result is correct — the inequality P(T≤a|X,W) ≤ P(T≤a|X,W,e=1) holds via a stochastic ordering argument (Chebyshev/FKG inequality applied to non-increasing functions of T, using T⊥C|X,W from Assumption 3.1). But the derivation as written is invalid. This matters because the derivation is the paper's central theoretical argument for connecting the coverage problem to weighted conformal prediction.

- **"Exact" coverage claim is materially overstated** — The paper repeatedly claims "exact miscoverage guarantee" (abstract, line 33). However, Theorem 4.1 (equation 4) gives a finite-sample bound with an estimation error term: coverage ≥ 1-α - ½E[|ω̃(X)-ω(X)|]. Theorem 4.2 is asymptotic (N,n→∞). The paper's real advantage over PAC methods (Gui et al. 2024, Davidov et al. 2025) is that the finite-sample error depends on weight estimation quality rather than an abstract PAC confidence parameter — a genuine but more nuanced improvement than "exact" throughout. PAC methods also converge to exact coverage asymptotically.

- **LPB optimization over τ lacks theoretical justification** — The procedure yields valid coverage for any fixed τ. The paper then optimizes τ* per test point (lines 162-166) to maximize the LPB. Since τ* is data-dependent, coverage at τ* need not equal coverage at any fixed τ — this is conceptually analogous to selective inference problems where optimizing a threshold using the same data breaks the guarantee. Table 1 shows empirical coverage maintained (0.958 for α=0.05), but only with 10 trials and no theoretical proof. The paper provides no argument that coverage is preserved under this optimization.

### Minor
- **Limited statistical reporting** — Table 1 uses only 10 independent trials for coverage estimates (line 116). With 10 trials, a true 90% coverage rate has a 95% confidence interval of roughly [0.60, 1.0] — far too wide to verify the guarantee. Figure 1 uses 50 trials but Table 1 (testing the important τ* optimization) uses 10. Coverage rates near hard thresholds require more trials.

### Trivial
None

## Nice-to-Haves
- Report the effective calibration sample size |I_cal^(w)| for each setting, to help readers assess how much data the conformal procedure actually uses under high censoring and treatment imbalance.
- Consider comparisons against Candès et al. (2023) on Type-I censoring settings where it applies, for completeness of the empirical comparison.

## Removed Points
These points are flagged to be removed, treat them with caution.
- **Missing baselines (Meixide et al. 2024, Qin et al. 2025)**: The paper explains these depend on asymptotic results under specific regularity conditions (line 38). Cannot verify external paper applicability. Removed per rules on missing related works.
- **Reproducibility concerns about model/benchmark availability**: Removed per hard rules — all cited entities are assumed to exist.
- **Generic concern about "effective calibration sample size could be very small"**: While true in principle, this is acknowledged briefly in the paper's Discussion (line 288) and is a generic concern for any weighted conformal method with imbalanced data. Without a specific setting where this fails, it is speculative.

## Novel Insights
The paper's genuinely novel insight is that the coverage probability for counterfactual survival prediction under right censoring can be upper-bounded via a density ratio reweighting that transforms the problem from the full population (where censoring creates missing data) to the uncensored treated subpopulation (where outcomes are fully observed). The key mathematical step — using the stochastic ordering between T|X,W and T|X,W,e=1 under the independence assumption T⊥C|X,W — enables this reduction. This insight, combined with weighted conformal prediction, yields a method that handles general right censoring (not just Type-I) with finite-sample bounds whose quality depends on weight estimation rather than abstract PAC parameters. This represents a genuine advance over prior work that either required Type-I censoring or achieved only PAC guarantees.

## Suggestions
- Rewrite the derivation of Equation (1) cleanly: state the key inequality P(T≤a|X,W) ≤ P(T≤a|X,W,e=1) directly via the stochastic ordering argument, then apply Bayes' rule to reach the reweighted form. This eliminates the confusing steps (ii)-(iii).
- Either provide a proof that conformal coverage is preserved under τ optimization (possibly by bounding the complexity of the optimization), or explicitly state that τ=α is the theoretically justified choice and the optimization is an empirical heuristic.
- Hedge the "exact" language: frame the contribution as providing a finite-sample bound depending on weight estimation quality plus asymptotic exactness, rather than "exact" throughout.

## Score and Decision

**Round 1 bracket: 5.5–6.5.**

The paper is clearly stronger than the rejected Dose-Response CP paper (avg 5.80, which lacked theory and real data) and comparable to the accepted Probabilistic CP paper (avg 6.00, which had cleaner presentation but a less ambitious setting). It sits below the Wasserstein-CP (avg 6.67) and Conformal Risk Control (avg 7.00) papers, which have cleaner theory and broader impact. The central derivation errors and "exact" overclaims are significant presentation issues but not fundamental correctness problems — the final results are sound, the methodology is novel, and the empirical validation is strong. The paper's contribution to combining general right-censored data with exact marginal coverage for counterfactual survival prediction is genuine and non-trivial.

**Final score: 6.0** — A solid paper with genuine contributions that has presentation and framing issues that should be addressed but do not undermine the core contribution.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>